The goal of the Cancer Prevention & Control Program is to apply the expertise of behavioral, basic, and clinician-scientists to conduct innovative and impactful cancer research that reduces Colorado’s cancer burden. To achieve this goal, CPC brings together outstanding transdisciplinary, well-funded scientists with strengths in public health, psychology, epidemiology, economics, basic science, and cancer care delivery. The program has 57 members, including 43 full members and 14 mentored members from many institutions and represents 24 departments and 7 schools; most members hold primary affiliations with the University of Colorado Anschutz Medical Center, University of Colorado Boulder, and Colorado State University.
Cancer Prevention and Control research has led to advancements in primary and clinical preventive services, statewide policies, and improved cancer survivorship. Cancer Prevention and Control investigators studied promising agents in pre-clinical studies, identified breast cancer risk factors in Hispanic women, developed and operated the Colorado Colorectal Screening Program, made advancements in the understanding of obesity and breast cancer, and affected cancer prevention and control policy across the state.
Dr. Fischer is an associate professor in the Division of General Internal Medicine, Department of Medicine in the School of Medicine at the University of Colorado Anschutz Medical Campus. Fischer is a geriatrician by training and a practicing palliative care clinician and researcher. Her work has focused on examining treatment preferences and outcomes at the end of life through a disparity and equity lens. Building on this work, she has developed innovative lay patient navigator interventions to improve palliative care outcomes for Hispanics across the Catchment. She is part of the leadership team for the NIH-funded Palliative Care Research Cooperative and is actively involved in federally and foundationally funded rigorous multi-site palliative care research trials. She has served on NIH and PCRC study sections and is currently a standing member of NIH’s Interdisciplinary Clinical Care in Specialty Setting study section. Dr. Fischer co-leads an NIH-funded T32 in palliative care and aging. Through her work with a national Palliative Care T32 collaborative, the American Academy of Hospice and Palliative Medicine and State of the Science, and the PCRC, Dr. Fischer is helping to shape the next generation of palliative care researchers. Since joining the Cancer Control and Prevention leadership team in 2021, she has worked closely with Drs. Studts and Agarwal to grow the survivorship and palliative care aspects of the program and champion disparities research across all the programs within the Cancer Center.
All events are the second Wednesday of the month and held from Noon to 1 p.m. on Zoom.
Contact Ellen.Valentine@ucdenver.edu for questions.
Preference Assessment Methods: Use in Cancer Care and Medical Decision-Making Research
Marilyn M. Schapira, MD, MPH
Yoga for the Treatment of Insomnia and Fatigue Among Cancer Survivors
Karen Mustian, PhD, MPH
Beyond a Closed Ended Question: Exploring the Decision to Screen or Not for Lung Cancer
Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN
Epidemiology of Multiple Myeloma and Related Precursor States - A Model for Early Detection
Elizabeth E. Brown, PhD, MPH
Ovarian Cancer: Epidemiologic Research and Future Challenges
Linda Cook, PhD
Cancer Disparities in the 21st Century
Robert A. Winn, MD | VCU